Veröffentlicht: 10 Mai 2024
Epalinges
100%
Festanstellung
Haya Therapeutics SA
Jobs online gefunden
Conditions of Employment: Proof of Eligibility to work in Switzerland (Swiss work permit or Swiss / European citizenship)
So, if you think you are a strong fit for this position, please apply today!
Please specify the position you are applying for and use the “LAB-MNGT” identifier in your cover letter and email subject line.
The position comes with an excellent compensation and benefits package.
About the job
We are seeking highly motivated candidates to join our headquarters in Lausanne.
You will be joining a dynamic start-up to improve and implement operations and logistics according to the incoming needs. You will help with enrollments of new employees and be implicated on some financial and high technological projects such as the implementation of the ERP.
HAYA seeks candidates who are creative, goal-oriented, excellent communicators, motivated to learn new skills and work collaboratively in a fast-paced entrepreneurial environment.
Primary responsibilities
Requirements
The ideal candidate for this position needs:
Core Values:
HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), - the ‘dark genomes’ information processing features and ‘source code’.
HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing a pipeline of lncRNA-targeting candidates for the cell-specific treatment of diseases in other tissues, including the lungs and the microenvironment of solid tumor cancers.
Headquartered at the life sciences park Biopôle in Lausanne, Switzerland with laboratory facilities at JLABS @ San Diego, HAYA is led by a world-class team of experts in programmable and precision RNA-targeted therapeutics and is supported by a strong investor consortium. HAYA’s mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility than existing treatments.